1-11 of 11
titration method
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Insulin Titration Recommendations When Using Glucagon-Like Peptide 1 Receptor Agonist Therapy in Adults With Type 1 Diabetes

Zeb I. Saeed, Halis K. Akturk, Grazia Aleppo, Davida Kruger, Carol J. Levy, Julia K. Mader, Jennifer L. Sherr, Viral N. Shah
Journal: Clinical Diabetes
Clin Diabetes 2025;43(1):131–138
https://doi.org/10.2337/cd24-0067
Published: 20 September 2024
View articletitled, Insulin Titration Recommendations When Using Glucagon-Like Peptide 1 Receptor Agonist Therapy in Adults With Type 1 Diabetes
Open the PDF for Insulin Titration Recommendations When Using Glucagon-Like Peptide 1 Receptor Agonist Therapy in Adults With Type 1 Diabetes in another window
Journal Articles

Patients With Type 2 Diabetes Are Willing to Do More to Overcome Therapeutic Inertia: Results From a Double-Blind Survey

Steven V. Edelman, Richard Wood, Michelle Roberts, Jay H. Shubrook
Journal: Clinical Diabetes
Clin Diabetes 2020;38(3):222–229
https://doi.org/10.2337/cd19-0067
Published: 01 July 2020
View articletitled, Patients With Type 2 Diabetes Are Willing to Do More to Overcome Therapeutic Inertia: Results From a Double-Blind Survey
Open the PDF for Patients With Type 2 Diabetes Are Willing to Do More to Overcome Therapeutic Inertia: Results From a Double-Blind Survey in another window
Journal Articles

Clinical Use of IDegLira: Initiation to Titration After Basal Insulin

Mark Warren, Donna Steel
Journal: Clinical Diabetes
Clin Diabetes 2020;38(1):62–70
https://doi.org/10.2337/cd19-0015
Published: 01 January 2020
View articletitled, Clinical Use of IDegLira: Initiation to Titration After Basal Insulin
Open the PDF for Clinical Use of IDegLira: Initiation to Titration After Basal Insulin in another window
Journal Articles

Practical Guidance on Effective Basal Insulin Titration for Primary Care Providers

Louis Kuritzky, Timothy S. Reid, Carol H. Wysham
Journal: Clinical Diabetes
Clin Diabetes 2019;37(4):368–376
https://doi.org/10.2337/cd18-0091
Published: 01 October 2019
View articletitled, Practical Guidance on Effective Basal Insulin Titration for Primary Care Providers
Open the PDF for Practical Guidance on Effective Basal Insulin Titration for Primary Care Providers in another window
Journal Articles

Transitioning to Fixed-Ratio Combination Therapy: Five Frequently Asked Questions Health Care Providers Should Anticipate From Their Patients

Ian Blumer, Lucia M. Novak, Steven Edelman, Tricia Santos Cavaiola
Journal: Clinical Diabetes
Clin Diabetes 2019;37(4):386–390
https://doi.org/10.2337/cd18-0102
Published: 01 October 2019
View articletitled, Transitioning to Fixed-Ratio Combination Therapy: Five Frequently Asked Questions Health Care Providers Should Anticipate From Their Patients
Open the PDF for Transitioning to Fixed-Ratio Combination Therapy: Five Frequently Asked Questions Health Care Providers Should Anticipate From Their Patients in another window
Journal Articles

Safety and Efficacy of Insulin Degludec/Liraglutide (IDegLira) and Insulin Glargine U100/Lixisenatide (iGlarLixi), Two Novel Co-Formulations of a Basal Insulin and a Glucagon-Like Peptide-1 Receptor Agonist, in Patients With Diabetes Not Adequately Controlled on Oral Antidiabetic Medications

Carol H. Wysham, Carlos Campos, Davida Kruger
Journal: Clinical Diabetes
Clin Diabetes 2018;36(2):149–159
https://doi.org/10.2337/cd17-0064
Published: 01 April 2018
View articletitled, Safety and Efficacy of Insulin Degludec/Liraglutide (IDegLira) and Insulin Glargine U100/Lixisenatide (iGlarLixi), Two Novel Co-Formulations of a Basal Insulin and a Glucagon-Like Peptide-1 Receptor Agonist, in Patients With Diabetes Not Adequately Controlled on Oral Antidiabetic Medications
Open the PDF for Safety and Efficacy of Insulin Degludec/Liraglutide (IDegLira) and Insulin Glargine U100/Lixisenatide (iGlarLixi), Two Novel Co-Formulations of a Basal Insulin and a Glucagon-Like Peptide-1 Receptor Agonist, in Patients With Diabetes Not Adequately Controlled on Oral Antidiabetic Medications in another window
Journal Articles

Insulin/Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy for the Treatment of Type 2 Diabetes: Are Two Agents Better Than One?

Vanita R. Aroda, Joseph R. Arulandu, Anthony J. Cannon
Journal: Clinical Diabetes
Clin Diabetes 2018;36(2):138–147
https://doi.org/10.2337/cd17-0065
Published: 01 April 2018
View articletitled, Insulin/Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy for the Treatment of Type 2 Diabetes: Are Two Agents Better Than One?
Open the PDF for Insulin/Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy for the Treatment of Type 2 Diabetes: Are Two Agents Better Than One? in another window
Journal Articles

Clinical Considerations for Insulin Pharmacotherapy in Ambulatory Care, Part Two: Review of Primary Literature and an Evidence-Based Approach for Treatment

Maria Miller Thurston, John A. Galdo, Catherine A. Bourg
Journal: Clinical Diabetes
Clin Diabetes 2015;33(1):20–27
https://doi.org/10.2337/diaclin.33.1.20
Published: 01 January 2015
View articletitled, Clinical Considerations for Insulin Pharmacotherapy in Ambulatory Care, Part Two: Review of Primary Literature and an Evidence-Based Approach for Treatment
Open the PDF for Clinical Considerations for Insulin Pharmacotherapy in Ambulatory Care, Part Two: Review of Primary Literature and an Evidence-Based Approach for Treatment in another window
Includes: Supplementary data
Journal Articles

A Perspective on Principles of Comparative Cost-Effectiveness Studies for Pharmacotherapy of Chronic Diseases

Pendar Farahani, MD, MSc
Journal: Clinical Diabetes
Clin Diabetes 2012;30(2):54–60
https://doi.org/10.2337/diaclin.30.2.54
Published: 01 April 2012
View articletitled, A Perspective on Principles of Comparative Cost-Effectiveness Studies for Pharmacotherapy of Chronic Diseases
Open the PDF for A Perspective on Principles of Comparative Cost-Effectiveness Studies for Pharmacotherapy of Chronic Diseases in another window
Journal Articles

Painful Diabetic Neuropathy: A Management-Centered Review

Mary Margaret Huizinga, MD, Amanda Peltier, MD, MSCI
Journal: Clinical Diabetes
Clin Diabetes 2007;25(1):6–15
https://doi.org/10.2337/diaclin.25.1.6
Published: 01 January 2007
View articletitled, Painful Diabetic Neuropathy: A Management-Centered Review
Open the PDF for Painful Diabetic Neuropathy: A Management-Centered Review in another window
Journal Articles

Case Study: Five Steps to Freedom: Dose Titration for Type 2 Diabetes Using Basal-Prandial-Correction Insulin Therapy

Susan S. Braithwaite, MD
Journal: Clinical Diabetes
Clin Diabetes 2005;23(1):39–43
https://doi.org/10.2337/diaclin.23.1.39
Published: 01 January 2005
View articletitled, Case Study: Five Steps to Freedom: Dose Titration for Type 2 Diabetes Using Basal-Prandial-Correction Insulin Therapy
Open the PDF for Case Study: Five Steps to Freedom: Dose Titration for Type 2 Diabetes Using Basal-Prandial-Correction Insulin Therapy in another window